Literature DB >> 35204

Kinetics and metabolism of clobazam in animals and man.

M Volz, O Christ, H M Kellner, H Kuch, H W Fehlhaber, D Gantz, P Hajdu, F Cavagna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 35204      PMCID： PMC1429544          DOI： 10.1111/j.1365-2125.1979.tb04664.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  METABOLISM OF DIAZEPAM IN RABBITS.

Authors:  G JOMMI; P MANITTO; M A SILANOS
Journal:  Arch Biochem Biophys       Date:  1964-11       Impact factor: 4.013

2.  Biotransformation of a 1,5-benzodiazepine, triflubazam, by man.

Authors:  K B Alton; R M Grimes; C Shaw; J E Patrick; J L McGuire
Journal:  Drug Metab Dispos       Date:  1975 Sep-Oct       Impact factor: 3.922

Review 3.  Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds.

Authors:  F Oesch
Journal:  Xenobiotica       Date:  1973-05       Impact factor: 1.908

4.  Metabolism of diazepam in rat, dog, and man.

Authors:  M A Schwartz; B A Koechlin; E Postma; S Palmer; G Krol
Journal:  J Pharmacol Exp Ther       Date:  1965-09       Impact factor: 4.030

5.  Diazepam metabolites in the rat: characterization by high-resolution mass spectrometry and nuclear magnetic resonance.

Authors:  M A Schwartz; P Bommer; F M Vane
Journal:  Arch Biochem Biophys       Date:  1967-08       Impact factor: 4.013
  5 in total
  18 in total

Review 1.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

Review 2.  Clobazam: pharmacological and therapeutic profile.

Authors:  G W Hanks
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 3.  Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.

Authors:  Jose de Leon; Edoardo Spina; Francisco J Diaz
Journal:  Ther Drug Monit       Date:  2013-02       Impact factor: 3.681

Review 4.  Disposition of anticonvulsants in childhood.

Authors:  J I Morrow; A Richens
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

5.  Benzodiazepines: clinical pharmacology and therapeutic use.

Authors:  C Bellantuono; V Reggi; G Tognoni; S Garattini
Journal:  Drugs       Date:  1980-03       Impact factor: 9.546

Review 6.  Active drug metabolites. An overview of their relevance in clinical pharmacokinetics.

Authors:  S Garattini
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

7.  PharmGKB summary: clobazam pathway, pharmacokinetics.

Authors:  Rachel Huddart; J Steven Leeder; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2018-04       Impact factor: 2.089

8.  Pharmacokinetic aspects of the interaction between clobazam and cimetidine.

Authors:  H G Grigoleit; P Hajdú; H K Hundt; D Koeppen; V Malerczyk; B H Meyer; F O Müller; P U Witte
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 9.  Clobazam : in patients with Lennox-Gastaut syndrome.

Authors:  Lily P H Yang; Lesley J Scott
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

Review 10.  Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment.

Authors:  P Gaudreault; J Guay; R L Thivierge; I Verdy
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.